Livzon Pharmaceutical Group logo

Livzon Pharmaceutical Group

Asia, Guangdong, China, Zhuhai

Description

Livzon is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products.

Investor Profile

Livzon Pharmaceutical Group has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (75%)
  • Series C (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Life Science
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Livzon Pharmaceutical Group frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 3
Solasta Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
4BIO Capital
Europe, England, United Kingdom, London
Co-Investments: 2
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
TPG Biotech
North America, California, United States, San Francisco
Co-Investments: 3
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 2
SL
North America, District of Columbia, United States, Washington
Co-Investments: 3
IP Group
Europe, England, United Kingdom, London
Co-Investments: 2

What are some of recent deals done by Livzon Pharmaceutical Group?

Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series CSep 21, 2022
Amount Raised: $30,000,000
Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series BMar 1, 2021
Amount Raised: $12,000,000
Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series BJan 7, 2021
Amount Raised: $47,000,000
LungLife AI

Thousand Oaks, California, United States

LungLife AI is a molecular diagnostics company that involves in the early detection and treatment of cancer.

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsMachine LearningMedical
Series BJun 17, 2015
Amount Raised: $25,500,000